The American College of Radiology (ACR) is pleased to announce Ella Kazerooni, MD, MS, and Daniel J. Durand, MD, have been appointed to the Centers for Medicare & Medicaid’s (CMS’) Medicare Evidence Development Coverage Advisory Committee (MEDCAC).
Kazerooni is a professor of radiology in the cardiothoracic radiology division of the University of Michigan Health System, Ann Arbor. She is chair of the ACR Committee on Lung Cancer Screening, chair of the ACR Committee on Thoracic Radiology and member of the ACR Commission on Body Imaging. Her research focuses on the development and evaluation of advanced imaging cardiothoracic technologies.
Since March 2016, Durand has been radiology chairman and executive director of clinical strategic alignment for LifeBridge Health, Baltimore. LifeBridge is an integrated health care provider including four acute care hospitals in Maryland. He was formerly director of accountable care in the Office of Johns Hopkins Physicians at Johns Hopkins HealthCare, Baltimore.
MedCAC is an influential advisory panel that provides recommendations to CMS on proposed National Coverage Determinations (NCDs) for new clinical procedures. NCDs are binding on all Medicare carriers, fiscal intermediaries, quality improvement organizations, health maintenance organizations, competitive medical plans and health care prepayment plans.
MEDCAC was established to provide guidance and recommendations on clinical topics under review for national coverage and analysis. The advisory panel evaluates medical literature, technology assessments and public testimony for coverage questions under its review, and it examines the benefits, harms and appropriateness of medical items and services that are covered or may be eligible for Medicare coverage.
The ACR extends a warm thank you and congratulations to Drs. Kazerooni and Durand for representing radiology on this important advisory panel.
For more information about MedCAC, please refer to the CMS website and MedCAC roster.